In Episode 32 of Hims House, hosts Jonathan Stern and Patrick Lester (aka Bayside) are joined by Antonio Linares — early Tesla and AMD investor, and one of the biggest Hims bulls on earth. Antonio lays out his long-term thesis: Hims isn’t just a telehealth brand, it’s a platform applying the Costco algorithm to healthcare, with world-class execution, a proprietary data loop, and the potential to birth an AI-driven digital twin of the human body.

The discussion covers the explosive potential of peptides, the role of network effects and personalized manufacturing, and why traditional pharma and Wall Street still underestimate Hims’ moat. Antonio also unpacks his concentrated investment strategy and the dynamics of retail vs. institutional conviction.

00:00 Introduction

01:00 Antonio's Investment Philosophy

02:15 The Costco Algorithm Applied to Healthcare

07:22 Comparing Hims to Other Tech Giants

10:51 Antonio's Approach to Portfolio Construction

18:50 Hims as a Platform & Tech Company

28:07 The Role of Data and AI in Healthcare

38:06 Peptides

42:35 Hims and Traditional Pharma

51:40 Andrew Dudum and Management

56:40 "Hims is a 100x. From Here."

01:08:48 Retail vs. Wall Street

Get full access to Hims House at himshouse.substack.com/subscribe